Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis
- PMID: 28342087
- PMCID: PMC5616173
- DOI: 10.1007/s10552-017-0873-3
Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis
Abstract
Purpose: Previous studies on pelvic inflammatory disease (PID) and the risk of ovarian cancer have found inconsistent results. We performed an updated meta-analysis to summarize the evidence of this association.
Methods: PubMed, Embase, and ISI web of science databases were searched through October 2016 for studies that investigated the PID and ovarian cancer association. Summary risk estimates were calculated using random-effects meta-analysis.
Result: Thirteen studies were eligible for analysis, which included six cohort studies and seven case-control studies. PID was associated with an increased risk of ovarian cancer overall [relative risk (RR) 1.24, 95% CI 1.06-1.44; I 2 = 58.8%]. In analyses stratified by race, a significant positive association was observed in studies conducted among Asian women (RR 1.69, 95% CI 1.22-2.34; I 2 = 0%), but marginally significant among Caucasians (RR 1.18, 95% CI 1.00-1.39; I 2 = 60.7%).Risk estimates were elevated in both cohort (RR1.32; 95% CI 1.05-1.66; I 2 = 64.7%) and case-control studies (RR 1.17; 95% CI 0.93-1.49; I 2 = 57.6%), albeit not statistically significant in case-control studies.
Conclusions: Our results suggested that PID might be a potential risk factor of ovarian cancer, with pronounced associations among Asian women. Large and well-designed studies with objective assessment methods, such as hospital records, are needed to confirm the findings of this meta-analysis.
Keywords: Inflammation; Meta-analysis; Ovarian cancer; Pelvic inflammatory disease.
Conflict of interest statement
Figures
References
-
- World Health Organization. Global Health Estimates 2015: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2015. Geneva: 2016. [Accessed 09 February 2017]. http://www.who.int/healthinfo/global_burden_disease/GlobalCOD_method_200....
-
- Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30. - PubMed
-
- Schwartz PE. Diagnosis and treatment of epithelial ovarian cancer. Minerva Ginecol. 2003;55:315–326. - PubMed
-
- Trope CG, Kaern J, Davidson B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):325–336. - PubMed
-
- National Cancer Institute. [Accessed 09 September 2016];Ovarian epithelial, fallopian tube, and primary peritoneal cancer Treatment (PDQ(R)): Health Professional Version. 2016 https://www.cancer.gov/types/ovarian/hp/ovarian-epithelial-treatment-pdq. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
